WaveMan · Form 4
Rhodes Jennifer J insider trades
> Search tickers & screens ⌘K
LIVE

Rhodes Jennifer J insider trades

Rhodes Jennifer J has filed 13 Form 4s with the SEC that we hold, for Elicio Therapeutics, Inc. (ANGN) (See Remarks) and Acadia Pharmaceuticals INC (ACAD) (EVP, CHIEF LEGAL OFFICER, SEC). Across all of them we count 0 purchases worth $0 and 9 sales worth $270.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($245.0K). The largest single trade was a sale of 6,950 shares of Acadia Pharmaceuticals INC worth $162.5K, dated 2026-02-09. The first filing on our record is dated 2021-07-15 and the latest 2026-03-26.

Elicio Therapeutics, Inc. (ANGN)

See Remarks · 8 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-14S, sale reported on Form 4431$4.7K2021-07-15
2021-07-21S, sale reported on Form 4432$4.7K2021-07-22
2021-08-16S, sale reported on Form 4445$4.8K2021-08-17
2021-09-14S, sale reported on Form 4430$4.6K2021-09-15
2021-10-14S, sale reported on Form 4430$3.7K2021-10-15
2021-11-15S, sale reported on Form 4433$1.9K2021-11-16
2021-12-14S, sale reported on Form 4451$1.1K2021-12-15

Acadia Pharmaceuticals INC (ACAD)

EVP, CHIEF LEGAL OFFICER, SEC · 5 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-02-09S, sale reported on Form 46,950$162.5K2026-02-10
2026-03-25S, sale reported on Form 43,844$82.5K2026-03-26
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1568249) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms